Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Neuronetics, Inc. | Director | Common Stock | 139K | $438K | $3.16 | May 25, 2023 | Direct |
Neuronetics, Inc. | Director | Stock Options (right to buy) | 16.1K | May 25, 2023 | Direct | ||
CONCERT PHARMACEUTICALS, INC. | Director | Common Stock | 0 | $8.33 | Mar 6, 2023 | Direct | |
CONCERT PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 0 | Mar 6, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
STIM | Neuronetics, Inc. | May 25, 2023 | 1 | $0 | 4 | May 30, 2023 | Director |
CNCE | CONCERT PHARMACEUTICALS, INC. | Mar 6, 2023 | 9 | $0 | 4 | Mar 6, 2023 | Director |
CNCE | CONCERT PHARMACEUTICALS, INC. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
STIM | Neuronetics, Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
CNCE | CONCERT PHARMACEUTICALS, INC. | Jun 10, 2021 | 2 | $0 | 4 | Jun 11, 2021 | Director |
STIM | Neuronetics, Inc. | May 27, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |